Dare Bioscience annual gross margin
2024
2025
Dare Bioscience Gross Margin Growth & History (DARE)
Dare Bioscience's gross margin was 71.29% for fiscal 2025.
View full Dare Bioscience company overviewDare Bioscience annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 71.29% | −28.71 pp |
| 2024 | 2024-12-31 | 100.00% | — |
Dare Bioscience quarterly gross margin
Q1.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −70.57% | — |
| Q1 2026 | 2026-03-31 | −58.95% | −158.95 pp |
| Q4 2025 | 2025-12-31 | 71.10% | — |
| Q3 2025 | 2025-09-30 | 100.00% | — |
| Q1 2025 | 2025-03-31 | 100.00% | — |
Dare Bioscience gross margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Dare Bioscience's gross margin decreased from 100.00% to 71.29%, a change of −28.71 percentage points. The latest reported quarter, Q2 2026, shows −70.57%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dare Bioscience source filings ↗